Dapagliflozin, as Add-on Therapy in Type 2 Diabetes Patients, Is Associated With a Reduction in Albuminuria and Serum Transaminase Levels

Overview of attention for article published in Frontiers in Clinical Diabetes and Healthcare, October 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 1,271 followers.

📰New Research! Check out this open access article 👉https://t.co/HGBxDeRjTg #DiabetesAwarenessMonth #type2diabetes https://t.co/eZO2ly19aE

23 Nov 2021

Reply Repost Favourite

New Research: Dapagliflozin, as Add-on Therapy in Type 2 Diabetes Patients, Is Associated With a Reduction in Albuminuria and Serum Transaminase Levels https://t.co/7SETR7qG1H #Diabetes

12 Oct 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.